
NZX profit dropped 62pc on Ralec case costs
NZX annual profit dropped 62 per cent as the stock market operator faced mounting costs from the protracted Ralec litigation.
NZX annual profit dropped 62 per cent as the stock market operator faced mounting costs from the protracted Ralec litigation.
Shares dropped, led lower by Chorus and Vector on regulation news, while A2 Milk Co and Trilogy gained.
The Tower board said the deal would not impact Tower insurance policies or the rights of policy holders.
Hellaby Holdings will delist from the NZX by March 8, after ASX-listed auto firm Bapcor succeeded in its $352 million takeover.
Harbour Asset Management has sold down its stake in Intueri Education Group.
NZ shares gained, led by A2 Milk Co and Fisher & Paykel Healthcare, while Metro Performance Glass plunged after disappointing investors.
Intueri Education Group will quit Australia by the end of the year after losing federal government subsidies.
Cash trading volumes on the NZX slowed in January, continuing December's trend, while the value of trading rose despite fewer small trades.
NZ shares dropped, led by Chorus and Fisher & Paykel Healthcare on continued concerns about US President Trump, while Heartland Bank and Air NZ rose.
Abano Healthcare has used Healthcare Partners Holdings' interim dividend to offset the cost of a partial takeover.
New Zealand shares dipped, led lower by Air New Zealand and Vector, with Arvida Group and Tegel Group Holdings rising.
New Zealand shares rose, with A2 Milk Co and high-yielding stocks such as Contact Energy and Genesis Energy gaining.
The independent directors of Hellaby Holdings now support a takeover bid by Bapcor after the offer was declared unconditional.
New Zealand shares fell, led lower by global markets, with ANZ Banking Group and A2 Milk Co down while Vital Healthcare Property Trust gained.
Shareholders who have accepted the offer will receive $3.60 per share within the next 7 days.
Pushpay Holdings says it's moving up the value chain and is in talks with large US vendors about its expanded product offering.
Pushpay says it is on track to reach its ACMR target of US$72 million and breakeven on a monthly cashflow basis by the end of calendar 2017.
Augusta Capital has dropped its High Court proceedings seeking orders requiring listed property investor NPT to call a meeting of shareholders.
Maverick shareholder advocate Bruce Sheppard reckons there's lessons for investors from the American Wild West.
Stock market operator NZX is "assessing" Plexure's recent trading after the stock soared 26 per cent a day ahead of an announcement.
New Zealand shares edged lower in light holiday trading, led by Ryman Healthcare and Kathmandu Holdings, while yield stocks Sky Network
New Zealand shares rose in abbreviated trading ahead of the Christmas holiday, led by blue-chip stocks including Auckland Airport and Spark.
Intueri's application for an A$6 million uplift in VHF funding has been denied.
NZ shares rose, snapping five days of decline, with Tegel Group Holdings and A2 Milk Co recovering from being sold off earlier in the week.
Hellaby provided first-half guidance for profit of up to $39.5 million, and promised a special dividend if the Bapcor offer fails.
New Zealand shares fell, led lower by Spark New Zealand and Scales Corp, while Orion Health Group rose from its record low.
Takeover target Hellaby hints at possible breakup on its own terms.
Concern has been raised after reports that Australia's The Star Entertainment Group wants a merger with SkyCity.
Affable markets boss fixed what was broken but didn't want to overstay his welcome.
NZ shares fell, dragged lower by A2 Milk Co on negative news from an Australian rival, while Fisher & Paykel Healthcare gained after a positive result in court.